The pace of activity aimed at creating a sovereign UK medtech regulatory system remains high, even after the flurry of policy announcements in late May. And as it gets deeper into the task, the Medicines and Healthcare products Regulatory Agency (MHRA) is aware that it retains the support of the UK industry. (Also see "UK Pro-Innovation Report Offers Promise For Medtech With MHRA/NICE Alignment" - Medtech Insight, 30 May, 2023.)
In mid-June, the UK government issued amended legislation to implement the extension of the periods during which certain EU-approved devices can still be sold in Great Britain; these extended periods...